PlainRecalls
FDA Drug Low Class III Terminated

Moxifloxacin Ophthalmic Solution USP, 0.5%, Sterile, 3mL Bottle, Rx Only, For Topical Ophthalmic Use Only, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ 08520, Made in India, NDC 65862-840-03.

Reported: January 22, 2020 Initiated: December 2, 2019 #D-0789-2020

Product Description

Moxifloxacin Ophthalmic Solution USP, 0.5%, Sterile, 3mL Bottle, Rx Only, For Topical Ophthalmic Use Only, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ 08520, Made in India, NDC 65862-840-03.

Reason for Recall

Discoloration: Market complaints of discoloration in Moxifloxacin Ophthalmic Solution.

Details

Recalling Firm
AuroMedics Pharma LLC
Units Affected
100,080 bottles
Distribution
Nationwide in the U.S.
Location
East Windsor, NJ

Frequently Asked Questions

What product was recalled?
Moxifloxacin Ophthalmic Solution USP, 0.5%, Sterile, 3mL Bottle, Rx Only, For Topical Ophthalmic Use Only, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ 08520, Made in India, NDC 65862-840-03.. Recalled by AuroMedics Pharma LLC. Units affected: 100,080 bottles.
Why was this product recalled?
Discoloration: Market complaints of discoloration in Moxifloxacin Ophthalmic Solution.
Which agency issued this recall?
This recall was issued by the FDA Drug on January 22, 2020. Severity: Low. Recall number: D-0789-2020.